Jason Neil

Jason Neil is a highly experienced scientist specializing in chemical proteomics, with a comprehensive background in mass spectrometry and therapeutic development. At Antares Therapeutics, Jason currently serves as Senior Principal Scientist, focusing on the discovery and characterization of novel mechanisms to target key signaling proteins and transcription factors in cancer. Previous roles include Senior Principal Scientist and Principal Scientist at Scorpion Therapeutics, where Jason advanced precision therapeutic development, and Senior Scientist at Thermo Fisher Scientific, where Jason concentrated on antibiotic resistance proteins. Academic credentials include a PhD in Pharmacology from the University of Colorado Anschutz Medical Campus and a BSc in Zoology/Biomedical Science from the University of Guelph. Furthermore, Jason has expanded expertise through postdoctoral research at MIT and early career roles at Kent State University and Penn State University. Jason's recent education includes a program in Data Science and Machine Learning at MIT.